![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 45/06 | |
A61K 31/365 | |||
A61K 31/5377 | |||
A61K 31/444 | |||
A61K 31/423 | |||
A61P 7/02 |
(11) | Number of the document | 3213749 |
(13) | Kind of document | T |
(96) | European patent application number | 15854130.0 |
Date of filing the European patent application | 2015-10-30 | |
(97) | Date of publication of the European application | 2017-09-06 |
(45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2015/093305 |
Date | 2015-10-30 |
(87) | Number | WO 2016/066128 |
Date | 2016-05-06 |
(30) | Number | Date | Country code |
201410606703 | 2014-10-30 | CN |
(72) |
SUN, Yi, CN
|
(73) |
Chengdu Baiyu Pharmaceutical Co., Ltd.,
Liu Tai Avenue No. 433 Chengdu National Cross-Straits Science and Technology Industrial Development Park Wenjiang District, Chengdu, Sichuan 610041,
CN
|
(54) | PHARMACEUTICAL COMPOSITION CONTAINING GINKGOLIDE B AND XA FACTOR INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF |
PHARMACEUTICAL COMPOSITION CONTAINING GINKGOLIDE B AND XA FACTOR INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF |